Literature DB >> 19538146

Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.

Vladimir N Uversky1, David Eliezer.   

Abstract

Parkinson's disease (PD) is a slowly progressive movement disorder that results from the loss of dopaminergic neurons in the substantia nigra, a small area of cells in the mid-brain. PD is a multifactorial disorder with unknown etiology, in which both genetic and environmental factors play important roles. Substantial evidence links alpha-synuclein, a small highly conserved presynaptic protein with unknown function, to both familial and sporadic PD. Rare familial cases of PD are associated with missense point mutations in alpha-synuclein, or with the hyper-expression of the wild type protein due to its gene duplication/triplication. Furthermore, alpha-synuclein was identified as the major component of amyloid fibrils found in Lewy body and Lewy neurites, the characteristic proteinaceous deposits that are the diagnostic hallmarks of PD. alpha-Synuclein is abundant in various regions of the brain and has two closely related homologs, beta-synuclein and gamma-synuclein. When isolated in solution, the protein is intrinsically disordered, but in the presence of lipid surfaces alpha-synuclein adopts a highly helical structure that is believed to mediate its normal function(s). A number of different conformational states of alpha-synuclein have been observed. Besides the membrane-bound form, other critical conformations include a partially-folded state that is a key intermediate in aggregation and fibrillation, various oligomeric species, and fibrillar and amorphous aggregates. A number of intrinsic and extrinsic factors that either accelerate or inhibit the rate of alpha-synuclein aggregation and fibrillation in vitro are known. There is a strong correlation between the conformation of alpha-synuclein (induced by various factors) and its rate of fibrillation. The aggregation process appears to be branched, with one pathway leading to fibrils and another to oligomeric intermediates that may ultimately form amorphous deposits. The molecular basis of Parkinson's disease appears to be tightly coupled to the aggregation of alpha-synuclein and the factors that affect its conformation. This review focuses on the contributions of Prof. Anthony L. Fink to the field and presents some recent developments in this exciting area.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538146      PMCID: PMC3786709          DOI: 10.2174/138920309789351921

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  245 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Solvent-induced collapse of alpha-synuclein and acid-denatured cytochrome c.

Authors:  A S Morar; A Olteanu; G B Young; G J Pielak
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

Review 3.  Protein folding revisited. A polypeptide chain at the folding-misfolding-nonfolding cross-roads: which way to go?

Authors:  V N Uversky
Journal:  Cell Mol Life Sci       Date:  2003-09       Impact factor: 9.261

4.  Nuclear localization of alpha-synuclein and its interaction with histones.

Authors:  John Goers; Amy B Manning-Bog; Alison L McCormack; Ian S Millett; Sebastian Doniach; Donato A Di Monte; Vladimir N Uversky; Anthony L Fink
Journal:  Biochemistry       Date:  2003-07-22       Impact factor: 3.162

5.  Structure and dynamics of micelle-bound human alpha-synuclein.

Authors:  Tobias S Ulmer; Ad Bax; Nelson B Cole; Robert L Nussbaum
Journal:  J Biol Chem       Date:  2004-12-22       Impact factor: 5.157

Review 6.  Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species.

Authors:  H Ischiropoulos
Journal:  Arch Biochem Biophys       Date:  1998-08-01       Impact factor: 4.013

Review 7.  Methionine oxidation, alpha-synuclein and Parkinson's disease.

Authors:  Charles B Glaser; Ghiam Yamin; Vladimir N Uversky; Anthony L Fink
Journal:  Biochim Biophys Acta       Date:  2004-11-25

8.  Widespread occurrence of alpha-synuclein/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies.

Authors:  K Wakabayashi; M Yoshimoto; T Fukushima; R Koide; Y Horikawa; T Morita; H Takahashi
Journal:  Neuropathol Appl Neurobiol       Date:  1999-10       Impact factor: 8.090

Review 9.  Synucleinopathies: clinical and pathological implications.

Authors:  J E Galvin; V M Lee; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-02

10.  Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.

Authors:  I-Hsuan Liu; Vladimir N Uversky; Larissa A Munishkina; Anthony L Fink; Willi Halfter; Gregory J Cole
Journal:  Glycobiology       Date:  2005-07-21       Impact factor: 4.313

View more
  115 in total

Review 1.  Parkinson's disease: insights from pathways.

Authors:  Mark R Cookson; Oliver Bandmann
Journal:  Hum Mol Genet       Date:  2010-04-26       Impact factor: 6.150

2.  Transient β-hairpin formation in α-synuclein monomer revealed by coarse-grained molecular dynamics simulation.

Authors:  Hang Yu; Wei Han; Wen Ma; Klaus Schulten
Journal:  J Chem Phys       Date:  2015-12-28       Impact factor: 3.488

3.  Deuteration of Escherichia coli enzyme I(Ntr) alters its stability.

Authors:  Grzegorz Piszczek; Jennifer C Lee; Nico Tjandra; Chang-Ro Lee; Yeong-Jae Seok; Rodney L Levine; Alan Peterkofsky
Journal:  Arch Biochem Biophys       Date:  2010-12-24       Impact factor: 4.013

4.  α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer.

Authors:  Bruno Fauvet; Martial K Mbefo; Mohamed-Bilal Fares; Carole Desobry; Sarah Michael; Mustafa T Ardah; Elpida Tsika; Philippe Coune; Michel Prudent; Niels Lion; David Eliezer; Darren J Moore; Bernard Schneider; Patrick Aebischer; Omar M El-Agnaf; Eliezer Masliah; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

5.  N-terminal acetylation of α-synuclein induces increased transient helical propensity and decreased aggregation rates in the intrinsically disordered monomer.

Authors:  Lijuan Kang; Gina M Moriarty; Lucy A Woods; Alison E Ashcroft; Sheena E Radford; Jean Baum
Journal:  Protein Sci       Date:  2012-06-11       Impact factor: 6.725

6.  Expanding the proteome: disordered and alternatively folded proteins.

Authors:  H Jane Dyson
Journal:  Q Rev Biophys       Date:  2011-07-01       Impact factor: 5.318

7.  Methionine oxidation stabilizes non-toxic oligomers of alpha-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions.

Authors:  Wenbo Zhou; Chunmei Long; Stephen H Reaney; Donato A Di Monte; Anthony L Fink; Vladimir N Uversky
Journal:  Biochim Biophys Acta       Date:  2009-12-21

8.  Computational analysis of fluid flow within a device for applying biaxial strain to cultured cells.

Authors:  Jason Lee; Aaron B Baker
Journal:  J Biomech Eng       Date:  2015-03-05       Impact factor: 2.097

Review 9.  Hydrogen-exchange mass spectrometry for the study of intrinsic disorder in proteins.

Authors:  Deepa Balasubramaniam; Elizabeth A Komives
Journal:  Biochim Biophys Acta       Date:  2012-10-22

10.  Potassium depolarization and raised calcium induces α-synuclein aggregates.

Authors:  Jordan Follett; Bonnie Darlow; Mathew B Wong; Jacob Goodwin; Dean L Pountney
Journal:  Neurotox Res       Date:  2012-12-19       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.